The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI
Bioengineering · 09.10.2024 · 11 (10) · 1006
DOI: 10.3390/bioengineering11101006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering, online erschienen am 09.10.2024. Verfasst von Roxana Iacob und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The APC was funded by "Victor Babes" University of Medicine and Pharmacy Timisoara, “Victor Babes” University of Medicine and Pharmacy Timisoara.
Abstract (Originalsprache)
Prostate cancer is the second most common cancer in men and a leading cause of death worldwide. Early detection is vital, as it often presents with vague symptoms such as nocturia and poor urinary stream. Diagnostic tools like PSA tests, ultrasound, PET-CT, and mpMRI are essential for prostate cancer management. The PI-RADS system helps assess malignancy risk based on imaging. While mpMRI, which includes T1, T2, DWI, and dynamic contrast-enhanced imaging (DCE), is the standard, bpMRI offers a contrast-free alternative using only T2 and DWI. This reduces costs, acquisition time, and the risk of contrast-related side effects but has limitations in detecting higher-risk PI-RADS 3 and 4 lesions. This study compared bpMRI’s diagnostic accuracy to mpMRI, focusing on prostate volume and PI-RADS scoring. Both methods showed strong inter-rater agreement for prostate volume (ICC 0.9963), confirming bpMRI’s reliability in this aspect. However, mpMRI detected more complex conditions, such as periprostatic fat infiltration and iliac lymphadenopathy, which bpMRI missed. While bpMRI offers advantages like reduced cost and no contrast use, it is less effective for higher-risk lesions, making mpMRI more comprehensive.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
- Department of Anatomy and Embriology, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
- Research Center for Medical Communication, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
- Field of Applied Engineering Sciences, Specialization Statistical Methods and Techniques in Health and Clinical Research, Faculty of Mechanics, 'Politehnica' University Timisoara, Mihai Viteazul Boulevard No. 1, 300222…
- Department of Radiology and Medical Imaging, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
- Research Center for Pharmaco-Toxicological Evaluations, 'Victor Babes' University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania.
ORCID-Profile: Roxana Iacob, Emil Robert Stoicescu
Förderung
- The APC was funded by "Victor Babes" University of Medicine and Pharmacy Timisoara
- “Victor Babes” University of Medicine and Pharmacy Timisoara
Zitieren
APA
Iacob, R., Manolescu, D., Stoicescu, E. R., Cerbu, S., Bardan, R., Ghenciu, L. A., & Cumpănaș, A. (2024). The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI. Bioengineering, 11(10), 1006. https://doi.org/10.3390/bioengineering11101006
Vancouver
Iacob R, Manolescu D, Stoicescu ER, Cerbu S, Bardan R, Ghenciu LA, et al. The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI. Bioengineering. 2024;11(10):1006. doi:10.3390/bioengineering11101006
BibTeX
@article{Iacob2024,
author = {Iacob, Roxana and Manolescu, Diana and Stoicescu, Emil Robert and Cerbu, Simona and Bardan, Răzvan and Ghenciu, Laura Andreea and Cumpănaș, Alin},
title = {The Diagnostic Value of bpMRI in Prostate Cancer: Benefits and Limitations Compared to mpMRI},
journal = {Bioengineering},
year = {2024},
volume = {11},
number = {10},
pages = {1006},
doi = {10.3390/bioengineering11101006}
}
EUVIMED